Relief Therapeutics Holding AG
SIX:RLF.SW
2.15 (CHF) • At close July 4, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CHF.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 8.417 | 6.033 | 6.081 | 3.321 | 0 | 0 | 0.567 | 0 | 0.015 | 0.256 | 19.49 | 20.714 | 34.932 | 0 | 0.386 | 13.74 | 14.545 | 14.827 | 2.48 |
| Kosten van de omzet
| 2.575 | 1.92 | 18.108 | 11.907 | 0 | 0.001 | 0.055 | 0.003 | 0.211 | 2.082 | 12.683 | 13.395 | 14.789 | 0 | 0 | 0 | 0 | 0 | 0.43 |
| Brutowinst
| 5.842 | 4.113 | 4.831 | -8.586 | 0 | -0.001 | 0.512 | -0.003 | -0.196 | -1.826 | 6.807 | 7.32 | 20.143 | 0 | 0.386 | 13.74 | 14.545 | 14.827 | 2.05 |
| Brutowinstmarge
| 0.694 | 0.682 | 0.794 | -2.585 | 0 | 0 | 0.903 | 0 | -13.067 | -7.131 | 0.349 | 0.353 | 0.577 | 0 | 1 | 1 | 1 | 1 | 0.827 |
| Onderzoek- en ontwikkelingskosten
| 1.357 | 1.328 | 12.393 | 19.024 | 13.645 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.904 | 54.7 | 14.548 | 20.146 | 20.173 | 11.291 | 4.677 |
| Algemene en administratieve kosten
| 9.242 | 17.229 | 20.745 | 15.871 | 2.838 | 0.566 | 0.86 | 0.704 | 0.963 | 0.028 | 2.192 | 0.513 | 3.72 | 2.672 | 1.683 | 2.071 | 1.191 | 1.509 | 0 |
| Verkoop- en marketingkosten
| 0.588 | 2.2 | 3.307 | 0.365 | 2.627 | 0.349 | 0.346 | 0.989 | 0.04 | 0 | 0.03 | 0.066 | 0.155 | 1.796 | 3.403 | 3.632 | 2.351 | 3.762 | 0 |
| Verkoop-, algemene en administratieve kosten
| 9.83 | 19.429 | 24.052 | 6.935 | 5.492 | 0.915 | 0.643 | 1.242 | 0.945 | 0.028 | 2.222 | 3.365 | 3.728 | 4.467 | 5.087 | 5.703 | 3.541 | 5.27 | 3.517 |
| Overige kosten
| 13.54 | 94.184 | 19.897 | -0.665 | -0.161 | -0.031 | -0.85 | -0.028 | 14.624 | 1.965 | 1.483 | 18.213 | 2.783 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bedrijfskosten
| 24.727 | 114.941 | 56.871 | 26.624 | 19.298 | 0.946 | 0.788 | 1.242 | 16.293 | 1.993 | 20.477 | 18.793 | 4.494 | 59.167 | 19.634 | 25.848 | 23.714 | 16.562 | 8.194 |
| Bedrijfsresultaat
| -18.885 | -110.828 | -52.04 | -34.306 | -19.298 | -0.947 | -0.5 | -1.245 | -16.489 | -3.819 | -12.104 | -11.559 | -6.18 | -59.167 | -19.248 | -12.108 | -9.169 | -1.734 | -6.143 |
| Bedrijfsresultaat ratio
| -2.244 | -18.37 | -8.558 | -10.33 | 0 | 0 | -0.882 | 0 | -1,099.267 | -14.911 | -0.621 | -0.558 | -0.177 | 0 | -49.816 | -0.881 | -0.63 | -0.117 | -2.477 |
| Totaal overige inkomsten en kosten netto
| -0.471 | -0.856 | -2.276 | -1.219 | 13.037 | -11.215 | 0.084 | -0.656 | -0.325 | 0 | -0.017 | -0.963 | -0.854 | 0.001 | -0.149 | -0.114 | -0.232 | -0.031 | -0.869 |
| Inkomen voor belasting
| -19.356 | -111.684 | -54.316 | -35.525 | -6.261 | -12.162 | -0.416 | -1.901 | -16.814 | -0.081 | -7.332 | -12.522 | -1.964 | -59.166 | -19.397 | -12.222 | -9.401 | -1.765 | -7.012 |
| Inkomen voor belasting ratio
| -2.3 | -18.512 | -8.932 | -10.697 | 0 | 0 | -0.734 | 0 | -1,120.933 | -0.316 | -0.376 | -0.605 | -0.056 | 0 | -50.202 | -0.889 | -0.646 | -0.119 | -2.827 |
| Belastingkosten
| -2.237 | -13.503 | -3.526 | -0.82 | 1.567 | -4.702 | 0.02 | 0.986 | 0.02 | -0.088 | -0.171 | -0.235 | -0.318 | -0.001 | 0.149 | -0.008 | 0.232 | 0.235 | 0.2 |
| Nettowinst
| -17.119 | -98.181 | -50.79 | -34.705 | -7.828 | -7.46 | -0.436 | -2.887 | -16.834 | -9.154 | -12.401 | -12.239 | -1.297 | -59.166 | -19.397 | -12.214 | -9.401 | -2 | -7.225 |
| Nettowinstmarge
| -2.034 | -16.274 | -8.352 | -10.45 | 0 | 0 | -0.769 | 0 | -1,122.267 | -35.743 | -0.636 | -0.591 | -0.037 | 0 | -50.202 | -0.889 | -0.646 | -0.135 | -2.913 |
| WPA (Winst Per Aandeel)
| -1.36 | -8.35 | -4.8 | -3.86 | -1.3 | -1.42 | -0.085 | -0.58 | -5.32 | -0.055 | -10.34 | -28.43 | -7.45 | -343.4 | -116.67 | -9.02 | -58.39 | -7.67 | -43.3 |
| Verwaterde WPA
| -1.36 | -8.35 | -4.8 | -3.86 | -1.3 | -1.42 | -0.085 | -0.58 | -5.32 | -0.055 | -10.34 | -28.43 | -7.45 | -343.4 | -116.8 | -9.02 | -58.39 | -6 | -43.3 |
| EBITDA
| -16.58 | -108.036 | -49.022 | -32.692 | -6.092 | -0.946 | -0.259 | -1.733 | -16.48 | -0.081 | -6.022 | -9.878 | 0.478 | -57.13 | -15.381 | -8.189 | -4.977 | 2.27 | -5.574 |
| EBITDA ratio
| -1.97 | -17.908 | -8.062 | -9.844 | 0 | 0 | -0.457 | 0 | -1,098.667 | -0.316 | -0.309 | -0.477 | 0.014 | 0 | -39.808 | -0.596 | -0.342 | 0.153 | -2.247 |